DG de filiale ou d'unité stratégique

• Strategy definition, Growth acceleration & Go to Market alignment,
• Missions carried out in France and Germany at Biotronik Berlin & in several start-ups such as Virtualisurg, Wistim, Labtoo, Sancare & Urgentime
• Member of several expert communities & start-up accelerators - Senior advisor for private equity & market research organizations,

Family-owned company, leader in Infusion, Surgery, Implants & Dialysis, €5.5 billion revenue & 52 000 people.

(Revenue 2014, €185 million - 420 people located on different sites)

Role & Mission

• P&L management of several divisions & support functions including logistic Hospital Care (Infusion, Clinical Nutrition & Regional Anesthesia), Aesculap (Surgical equipment & Implants) & OPM (Stoma therapy & Incontinence & Wound Care),
• Legal representative & member of the local Executive Committee,

Achievements

• Defined & Implemented 2012-2015 Strategic plan based on 4 pillars: Customer Intimacy, Operation Experience, Innovation & Talents Management
• Implemented a matrixial go to market organizations (12 dedicated sales teams & 7 KAM),
• Developed Solution selling offerings to national GPO's, - Set up CRM "Salesforce" within a large team of 260 people,

Results

• Sales growth above the market, for all three Divisions,
• Reduction of Expense on Sales ratio according to the plan,
• Margin improvement delivered by a better product-mix management & with Clinical value selling proposition,

Family-owned company, leader in Infusion, Surgery, Implants & Dialysis, €5.5 billion revenue & 52 000 people.

(Revenue 2008, €123 million/140 people)

Role & Mission

• Manage 2 BU’s Hospital Care (Infusion, Clinical Nutrition & Regional Anesthesia) from 2003 to 2010 and simultaneously HC & Aesculap (Surgical instruments, Sutures & Implants) from 2008 to 2010

Achievements

• Aligned the two Business Unit on a unique Operating mechanism,
• Positioned the portfolio according to decision making process,
• Set-up, distributors sales channel for small customers in surgical instruments,
• Launched LVP Bottle Pack “Ecoflac” concept, in a very competitive market,
• Implemented 12 regional scientific experts to boost sales of pharma portfolio

Results

• Budget achieved all along the period,
• +3.6M€ operating profit due to cost management & digitalization (new tools),
• 50% market share in infusion therapy (LVP),
• 25% market share in parenteral clinical nutrition,

Worldwide leader in Diagnostic Imaging, $7 billion revenue in 2003

Multi-vendor Services Diagnostic Imaging

• Re-energized Multi-vendor Services DI business in Germany, UK, Italy & Turkey,
• Set-up European Pricing Committee reviewing profitability of each major deals,
• Generated revenue of 21M€ with a team of 70 people in 7 countries,

Family-owned company, Worldwide leader in respiratory care, ’01 Sales €805M

(Revenue in 2000, €34 million – 60 people)

• Definition and Implementation of operational business plans,
• Reorganized Customer Service department improving efficiency,
• Boosted sales of accessories/consumables business (+70% Revenue in 3 years),

(Revenue’97, €17M)

• Successful sales development in Italy, Greece & Switzerland in ventilation care,

"Operating Room" & Product Manager "Neonatal care"

Emergency products

.